Buys
Open market- Shares
- Avg price
- Total value
Richard Nolan Townsend - Chief Executive Officer, Director at Lexeo Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- LXEO on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Richard Nolan Townsend in Lexeo Therapeutics, Inc.
Sells
Open market- Shares
- -112,067
- Avg price
- $5.85
- Total value
- -$655,676
Net
Past year- Shares
- -112,067
- Share %
- -100%
- Total value
- -$655,676
Reported holdings for Richard Nolan Townsend in Lexeo Therapeutics, Inc.
Form 4 holding
Chief Executive Officer, Director
Lexeo Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 374,472
- Estimated value
- $1,854,085
- Report date
- 18 Aug 2026
- Price
- $4.95
- Ownership
- Direct
Form 4 holding
Chief Executive Officer, Director
Lexeo Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 646,665
- Estimated value
- Report date
- 04 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Richard Nolan Townsend in Lexeo Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.